Basaglar

Shares of Eli Lilly and Co (NYSE: LLY) gained more than 3 percent ahead of Thursday's market open after the company provided the investment community with its financial guidance and an update to a new insulin product. Financial Guidance Eli Lilly guided its full year fiscal 2016 earnings...